Efficacy and Safety of MEthylprednisolone Administered Intravenously for the Treatment of Patients With Active AnkyLosing spondyLitis (METALL)

NCT01790022 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: Methylprednisolone

Sponsor

Saratov State Medical University

Collaborators

[object Object]